US Patent Issued to Board of Regents, The University of Texas System on Aug. 11 for "TRNA-derived fragments as disease biomarkers and neuropathological regulators in Alzheimer's disease" (Texas Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,883, issued on Aug. 11, was assigned to Board of Regents, The University of Texas System (Austin, Texas).

"TRNA-derived fragments as disease biomarkers and neuropathological regulators in Alzheimer's disease" was invented by Xiaoyong Bao (Friendswood, Texas) and Xiang Fang (Friendswood, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes a method for treating Alzheimer's Disease, the method comprising the steps of: performing or having performed an assay that determines a level of one or more tRNA derived RNA fragments (tRFs), NOP2/Sun RNA methyltransferase 2 (NSun2), or angiogenin, in a biological sample when compare...